Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

BRIEF-Medipharm Labs, TerrAscend Enter Into Label Concentrate Supply Agreement

Published 2019-09-25, 06:48 a/m
© Reuters.  BRIEF-Medipharm Labs, TerrAscend Enter Into Label Concentrate Supply Agreement
LABS
-

Sept 25 (Reuters) - Medipharm Labs Corp LABS.TO :

* MEDIPHARM LABS - TERRASCEND WILL HAVE OPTION TO PURCHASE UP TO ADDITIONAL $105 MILLION OF CANNABIS CONCENTRATE OVER SAME PERIOD, IN DEAL

* MEDIPHARM LABS - DEAL HAS OPTION FOR 12 MONTH MUTUAL EXTENSION WHERE IF EXTENDED TERRASCEND WOULD BUY AT LEAST ABOUT $10 MILLION CANNABIS CONCENTRATE

* MEDIPHARM LABS AND TERRASCEND ENTER MAJOR PRIVATE LABEL CONCENTRATE SUPPLY AGREEMENT WITH POTENTIAL VALUE UP TO $192 MILLION

* MEDIPHARM LABS - WILL SUPPLY TERRASCEND WITH ABOUT $27 MILLION OF PRIVATE LABEL CANNABIS DISTILLATE, OVER 24-MONTHS COMMENCING SEPT

* MEDIPHARM LABS CORP - MULTI-YEAR SUPPLY AGREEMENT TO SUPPORT TERRASCEND'S ROLL OUT OF CANADIAN CANNABIS 2.0 DERIVATIVE PRODUCTS

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.